These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1437564)

  • 1. The basic RNA-binding domain of HIV-2 Tat contributes to preferential trans-activation of a TAR2-containing LTR.
    Chang YN; Jeang KT
    Nucleic Acids Res; 1992 Oct; 20(20):5465-72. PubMed ID: 1437564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H; Rice AP
    Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
    Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
    Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
    Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
    Delling U; Roy S; Sumner-Smith M; Barnett R; Reid L; Rosen CA; Sonenberg N
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6234-8. PubMed ID: 2068104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.
    Luo Y; Peterlin BM
    J Virol; 1993 Jun; 67(6):3441-5. PubMed ID: 8497060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.
    Echetebu CO; Rhim H; Herrmann CH; Rice AP
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):655-64. PubMed ID: 8207644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of exon 2 in optimal trans-activation by Tat of HIV type 2.
    Pagtakhan AS; Tong-Starksen SE
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1367-72. PubMed ID: 8573394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
    Elangovan B; Subramanian T; Chinnadurai G
    J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.
    Berkhout B; Gatignol A; Silver J; Jeang KT
    Nucleic Acids Res; 1990 Apr; 18(7):1839-46. PubMed ID: 2186367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Calnan BJ; Biancalana S; Hudson D; Frankel AD
    Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
    Taylor JP; Kundu M; Khalili K
    Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.
    Misumi S; Takamune N; Ohtsubo Y; Waniguchi K; Shoji S
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):297-304. PubMed ID: 15117453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.
    Gatignol A; Buckler-White A; Berkhout B; Jeang KT
    Science; 1991 Mar; 251(5001):1597-600. PubMed ID: 2011739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.